RESEARCH DOSSIER
Reinsurance Program Governance and ORSA Integration
Abstract. Reinsurance program governance concerns the institutional process through which an insurance undertaking chooses, approves, documents, operates, and continuously reassesses the transfer of insured losses to reinsurers or other risk-bearing counterparties. Own Risk and Solvency Assessment (ORSA) connects those choices to the undertaking's actual and prospective risk profile, capital resources, liquidity, risk appetite, and capacity to fulfill policyholder obligations. This monograph examines the integration of the two processes as a single decision problem whose outputs remain distinct: a reinsurance program alters contractual loss allocations, while ORSA assesses the resulting undertaking, including the new risks created by the transfer. The research establishes a source-critical account of the international supervisory architecture; compares the Insurance Core Principles of the International Association of Insurance Supervisors with the European Union's Solvency II framework, the United States' state-based ORSA model, Australia's prudential standards, and Canada's supervisory guidelines; and relates those prescriptions to established economic research on reinsurance demand, catastrophe capacity, and corporate risk management. It analyzes board accountability, management delegation, risk-appetite translation, treaty architecture, legal enforceability, counterparty security, model uncertainty, adverse market cycles, group structures, and supervisory reporting. A fully disclosed hypothetical portfolio demonstrates the differences between gross loss, contractual recovery, retained loss, counterparty impairment, collateral, liquidity timing, expected transfer, and capital vulnerability. A linked scenario design addresses repeated catastrophes, treaty exhaustion, unavailable reinstatements, correlated reinsurer deterioration, and multi-year prospective solvency. The principal finding is that effective governance makes reinsurance performance observable at three levels: the enforceable contract, the economic transformation of the insurer's loss distribution, and the ongoing capacity of the institution to meet obligations under stress. ORSA becomes decision-useful when these levels are reconciled with risk tolerance, capital and liquidity plans, and an auditable response to emerging variance. The conclusions constitute an original comparative and analytical synthesis of established scholarship and authoritative supervisory materials, without claiming a new theoretical doctrine or an empirically calibrated universal optimization model.
Keywords: Reinsurance program governance; own risk and solvency assessment; ORSA; enterprise risk management; risk appetite; reinsurance strategy; treaty design; capital adequacy; solvency; risk transfer; counterparty credit risk; basis risk; catastrophe excess of loss; quota-share reinsurance; reverse stress testing; liquidity; collateral; board oversight; reinsurance documentation; recovery risk; group risk; insurance supervision; International Association of Insurance Supervisors; Solvency II; NAIC; APRA; OSFI.
Introduction
An insurer may purchase a treaty that materially reduces modeled catastrophe losses and nevertheless remain exposed to failure through uncovered layers, ambiguous wording, late collections, reinsurer default, aggregate exhaustion, or inadequate liquid assets. Equally, an insurer may maintain a sophisticated ORSA report while operating a reinsurance program whose actual terms, reinstatement capacity, counterparty concentration, and claims-payment timing never enter the assessment. Both problems originate in the separation of institutional decision processes that should describe the same balance sheet and the same future obligations.
The IAIS reinsurance principle (IAIS, 2024, ICP 13.1) requires cedents to maintain programs appropriate to their business and integrated into overall risk and capital management strategies. The IAIS ERM and ORSA standards (IAIS, 2024, ICP 16.11–16.16) link board and senior-management responsibility, prospective financial resources, material risks, stress testing, counterparty exposures, and supervisory assessment. Their conjunction defines the central research question: under what institutional and financial conditions does the insurance-risk transfer selected by management remain a credible component of prospective solvency?
The answer depends on the precise identity of the transferred event, its contractual coverage, the timing and security of reimbursement, the internal decision authority, and the risk and capital assumptions used to evaluate the transaction. The NAIC explanation of reinsurance (NAIC, updated 2025) describes cession as a contractual transfer of risk between an insurer and a reinsurer. The cedent's underlying obligations to policyholders, its treaty rights against counterparties, and the applicable recognition rules must be represented separately. For the purpose of this study, reinsurance governance includes the internal decisions and controls needed to ensure that those representations remain consistent.
A comparison across jurisdictions has immediate scientific value. International standards set supervisory objectives. National legislation and enforceable prudential standards specify legal duties. Guidance communicates supervisory expectations, sometimes with different thresholds, report formats, and institutional vocabulary. An insurer's internal risk appetite, meanwhile, specifies decision criteria within its own business plan. These different normative layers can point in a common direction without imposing identical legal mechanisms on every insurer.
The research object is the cedent's reinsurance program as a governed component of ORSA, including its translation into balance-sheet, liquidity, and prospective risk assessments. The principal comparison covers five regulatory settings: IAIS international standards; the European Union under Solvency II; the United States under state law informed by the NAIC; Australian insurers subject to APRA standards; and federally regulated Canadian insurers under OSFI supervision. Academic evidence supplies economic explanations for reinsurance purchases and limits to market capacity. It does not establish compliance by any particular insurer.
The method is comparative institutional analysis combined with contractual mapping, transparent loss-transform calculations, scenario reconstruction, and source-critical interpretation. Regulatory provisions are distinguished by jurisdiction and authority; the economic illustrations are expressly hypothetical. Each scientific source is cited in the paragraph in which it supports a proposition, with full bibliographic identification in References. Original contract data, private ORSA submissions, confidential reinsurance prices, and internal board records are not available for this study. Consequently, the analysis evaluates mechanisms and documentary requirements rather than asserting how a named insurer implements them.
Concepts, History, and Evidence Sources
The economic and contractual object
Reinsurance is commonly purchased to reduce variability in the cedent's retained results, protect the solvency position against severe events, moderate capital demands, support underwriting capacity, or access specialist expertise. These goals differ in their relevant measures. Reduction of expected retained claims, reduction of a high loss quantile, stabilization of annual earnings, liquidity protection after an event, and regulatory capital recognition are neither numerically equivalent nor interchangeable. A program can improve one measure and leave another nearly unchanged.
Write the cedent's gross insured loss in a defined period as L, the amount contractually due from all reinsurers as R(L, W, A), and actual recoveries received by time t as C_t. W denotes operative treaty wording, including the insured event and aggregation rules; A describes annual limits, reinstatements, aggregate deductibles, and other program architecture. Contractual retained loss is N = L − R. Realized cash outflow before payment of all recoveries is L − C_t, to which paid ceded premiums, expenses, and other cash movements must be added for a full liquidity assessment. A receivable therefore affects accounting or economic risk differently from cash in hand.
The distinction becomes critical under credit stress. If R is contractually due but the counterparty ultimately pays R − D, where D denotes shortfall from default, dispute, enforceability failure, or other realization impairment, ultimate retained economic loss becomes N + D. Collateral or security may mitigate D, but collateral adequacy, permitted assets, valuation, concentration, and access conditions also require analysis. The fact that expected gross volatility falls following reinsurance does not itself establish lower realized volatility under joint insurance and counterparty stress.
A simple excess-of-loss contract with attachment a and occurrence limit m illustrates the legal-financial map. For a covered loss event, and ignoring coinsurance, expenses, coverage exclusions, aggregate caps, and reinstatement restrictions, R(L) = min(max(L − a, 0), m). The retained loss is L − R(L). Each omitted contractual feature matters: reinstatement provisions determine whether another event receives protection; aggregate limits determine exhaustion; occurrence definitions determine which claims combine; loss-adjustment expense provisions can change covered amounts; hours clauses can change aggregation; and exclusions can remove events from the function. A production ORSA must rebuild this mapping from operative contracts rather than relying on a generic layer diagram.
Institutional development and corporate demand
The economic literature explains why a risk-bearing insurer may itself buy insurance. Mayers and Smith's reinsurance-demand evidence (1990) used reported purchases by property–casualty insurers to investigate associations with ownership structure, size, geographic concentration, and line-of-business concentration. Those findings concern an observed historical sample and the determinants of purchases; they do not establish that a particular volume of cession is optimal or that greater cession always improves solvency.
A broader international investigation by Altuntas, Garven, and Rauch, global reinsurance-demand research (2018), examined 21,814 insurer-year observations from 33 countries over 2000–2012. Its conclusion that country-level factors remain economically and statistically significant after firm-level controls supports the institutional relevance of legal, fiscal, market, and supervisory environments. It does not warrant extrapolating a uniform treaty structure to all countries or treating those historical estimates as current placement prices.
Froot's catastrophe-risk market study (2001) identified historically limited purchases of catastrophe protection for the largest events and prices high relative to expected losses, examining restrictions on risk-bearing capacity and market power. These mechanisms explain why reinsurance decisions involve affordability, supply, and strategic constraints beyond actuarial expected cost. They also demonstrate why an ORSA should test protection that management would prefer to buy but might be unable to renew on acceptable terms.
The 2026 study by Cole and Eastman, reinsurance across corporate life cycles (2026), reports that reinsurance use varies with insurer life-cycle stages, including more intensive use in several nonmature phases in its study sample. This contemporary empirical result widens the set of potential explanatory variables without establishing a universal life-cycle rule. Management incentives, external financing conditions, group support, and market opportunities can interact with underwriting strategy.
Hierarchy of evidence and authority
International supervision provides one level of the evidentiary hierarchy. IAIS ICP 13 states that insurance-risk transfer creates credit, operational, and basis risks for the cedent even as it reduces underlying insurance risk. ICP 16 addresses enterprise risk management, the ORSA process, and the relationship between prospective financial resources and material risks. These standards concern supervisory expectations and assessment methodology; national implementation remains relevant to enforceable obligations.
The 2026 ICP 13 peer-review announcement (IAIS, April 21, 2026) reports participation by 80 jurisdictions and that 85% of members received ratings of Observed or Largely Observed in the thematic supervisory assessment. This is evidence of assessed supervisory observance, not evidence that 85% of individual reinsurance contracts are adequate, collectible, or compliant. The distinction between supervisory framework and firm behavior is indispensable.
The European Union's primary Solvency II provisions, related delegated regulation, and EIOPA guidance constitute a layered normative structure. NAIC model acts and manuals operate within the state-based U.S. legislative system. APRA prudential standards are binding on entities within their scope. OSFI guidelines convey expectations for federally regulated insurers in Canada. These instruments can be compared by the actual decision obligations they address: board approval, program documentation, forward-looking risk assessment, independent challenge, counterparty assessment, and supervisory reporting.
A valid research synthesis also separates descriptive evidence from normative prescription. An empirical correlation between cession and size is not a reinsurance limit; a regulatory capital benefit is not a guarantee of liquidity; supervisory recognition is not proof of ultimate recoverability; a model-derived return period is not a contractual trigger. The remainder of the study uses those separations to derive a governance structure consistent with the inspected evidence.
Board and Committee Responsibilities
Board ownership of the reinsurance strategy
The board establishes the undertaking's risk appetite and approves the strategic allocation of risk that management may retain, insure, or transfer. Senior management converts that position into treaty design, placement, controls, and operating procedures. Under IAIS ICP 13.1 (IAIS, 2024), senior management develops reinsurance-related risk strategy and the program, while the board approves the strategy and oversees its consistent implementation. IAIS guidance also expects regular performance review and supervisory challenge of inconsistencies between strategy and program.
A board mandate should specify the ultimate economic purpose of the program. An insurer expanding into earthquake-exposed property risks may require a catastrophe occurrence limit, a minimum reinsurance-security standard, and a maximum retained single-event loss. A long-tail casualty insurer may prioritize adverse-development protection, reserving volatility, and counterparty recoverability over the same catastrophe occurrence metric. A life insurer may assess mortality catastrophe or longevity cessions with very different duration, collateral, and operational concerns. A board that simply approves a ceded-premium budget has not articulated the full risk decision.
APRA's GPS 230 reinsurance standard (effective July 1, 2023) places ultimate responsibility for the reinsurance management framework on the relevant board and requires a board-approved Reinsurance Management Strategy (ReMS) connected to the broader risk-management framework, business plan, and Internal Capital Adequacy Assessment Process (ICAAP). The standard addresses the selection, implementation, monitoring, review, control, and documentation of arrangements. Its specificity demonstrates the operational meaning of board accountability: a documented strategy must survive translation into enforceable treaties and supervisory statements.
The APRA CPS 220 framework (in force from July 1, 2019) requires a board-approved risk appetite statement, risk management strategy, and business plan, forward-looking stress testing, risk-function independence, and timely reporting. The board must receive coherent views of material risks, including risks across group entities where applicable. In this structure, reinsurance is a controlled part of the broader institutional framework rather than a detached purchasing activity.
Decision rights and independent challenge
An effective allocation of responsibilities can be expressed as a sequence of decision rights. The board approves the risk appetite, strategic reinsurance objectives, and material changes; management proposes treaty structures, counterparties, and purchase terms; underwriting and actuarial staff estimate exposure and loss distributions; finance and treasury assess capital, financing, and cash flows; risk management challenges assumptions and alignment with tolerances; legal and compliance functions examine enforceability and supervisory treatment; internal audit assesses control design and operation independently. These are analytical responsibility categories, subject to the actual law and organizational structure of the insurer.
Decision quality depends on explicit disagreement resolution. Suppose the underwriting team assumes a catastrophe treaty covers a class of flood losses, while the legal review identifies a potentially conflicting event definition. The program owner must document the difference, request clarification or amendment, and model the conservative contractual interpretation until the issue is resolved. A solvency model that silently selects the more generous interpretation manufactures apparent risk transfer without corresponding legal certainty.
A decision memorandum should present at least five linked representations of the program: gross exposure; retained loss after contractual layers; stressed retained loss after counterparty impairment; cash required before recoveries are collected; and the projected solvency effect relative to risk appetite. Each representation needs its horizon and scope. A one-year occurrence exceedance probability, an ultimate reserve-development distribution, and a multi-year ORSA capital projection answer different questions.
The IAIS ICP 16 ORSA provisions (IAIS, 2024, especially 16.11–16.12) require board and senior-management responsibility for ORSA and consider all reasonably foreseeable material risks, including group, credit, market, concentration, operational, insurance, and liquidity risks as appropriate. The same standard identifies independent review, stress scenarios, aggregate counterparty exposure analysis, and supervisory evaluation as relevant elements. ORSA governance therefore gives an institutional forum for challenging a reinsurance purchase before and after placement.
Committee structure and feedback
A risk committee may review tolerance headroom, reverse stress scenarios, counterparty concentration, and model validation; an audit committee may oversee internal control and independent assurance; an underwriting or reinsurance committee may review placement terms and treaty performance. Committee names are less important than documented mandates, clear escalation, minutes, access to expertise, and board accountability. Delegation cannot eliminate the need for coherent information reaching the ultimate decision maker.
The feedback loop is essential. The original board decision reflects exposure data and market terms at a particular date. Between renewal dates, the insurer may grow in a concentrated region, acquire another portfolio, alter claims-reserving practices, experience a catastrophe, or encounter reinsurer deterioration. Each event can change the adequacy of a treaty without changing its printed limit. Management information should show both the contractual program and the changing portfolio to which it applies.
Governance must also address external brokers and outsourced modeling services. A broker can provide market intelligence, counterparty information, quotes, and placement documentation; a catastrophe-model provider can offer event distributions and loss estimates. Neither service substitutes for the cedent's duty to understand program scope, verify binding documentation, scrutinize assumptions, and manage conflicts of interest. The board needs assurance that key outsourced judgments can be independently challenged.
Group decisions and entity constraints
Reinsurance is often negotiated at group level, while policyholder obligations arise in legal entities. A group contract can produce attractive aggregate diversification and yet leave a particular subsidiary exposed because of retentions, settlement clauses, local asset rules, currency mismatches, recoverability, or restrictions on transferring resources. The group ORSA must therefore preserve entity-level evidence of protection as well as aggregate results.
This tension appears across the regulatory comparison. NAIC ORSA reporting supplements the legal-entity perspective with group risk and capital analysis; IAIS ICP 16 addresses group risks where applicable; APRA CPS 220 includes group-wide controls and visibility. A coherent group program should therefore reconcile: which entity bears the primary claim; which entity is party to the treaty; who holds collateral; where receivables arise; which capital calculation recognizes the transfer; and whether liquidity can reach the paying entity when due.
The Solvency II delegated risk-management system (Regulation (EU) 2015/35, Article 259) requires a documented risk-management strategy, decision procedures, defined risk tolerances, and monitoring reports. This supports an audit-ready record of who translated the treaty into the risk system and which decision consequences followed.
A useful governance test is counterfactual: would the insurer make the same underwriting and capital decisions if it assumed that one major reinsurance counterparty could not settle for six months during a large catastrophe? A board that has never seen the resulting legal-entity cash and solvency position lacks a complete view of its transfer decision.
Reinsurance Policy and Risk Appetite
Translating appetite into enforceable design
A risk appetite statement is a quantitative and qualitative statement of acceptable exposure, supported by limits, monitoring, and escalation. For reinsurance decisions, it may include maximum retained loss under defined events, net catastrophe loss at a stated model quantile, expected earnings volatility, net underwriting leverage, counterparty concentration, liquidity gap, and minimum prospective capital headroom. Each limit requires a denominator, time horizon, data convention, and response threshold.
A maximum event retention of $250 million is meaningful only if the insurer specifies whether it includes claims-adjustment expenses, multiple lines of business, aggregate event clustering, reinstatement costs, reinsurance premium, counterparty default, and disputes. A regulatory capital ratio specifies another outcome and may move differently from event retention. An insurer should therefore maintain a map from each declared limit to the contracts, modeled scenarios, and risk owners that determine it.
The EU Solvency II risk-management provision (Directive 2009/138/EC, Article 44) requires a risk-management system integrated into organizational decision making, covering risk interdependencies and risks beyond those included fully in the Solvency Capital Requirement. The delegated risk-management areas (Regulation (EU) 2015/35, Article 260) include procedures for selecting appropriate reinsurance and other risk-mitigation techniques and assessing the associated credit risk. The formal existence of a risk-mitigation transaction must therefore be accompanied by an understanding of its own risk mechanisms.
Reinsurance forms and their governance consequences
Proportional quota-share arrangements distribute a stated share of covered premiums and claims, subject to treaty terms. They can change exposure across a broad range of loss sizes and underwriting results. Surplus share treaties depend on risk-specific retained lines and declared amounts. Nonproportional excess-of-loss covers respond when covered loss passes an attachment, with limit, aggregation, and reinstatement terms controlling the recovery. Stop-loss or aggregate excess covers apply to a cumulative loss measure over a defined period. Facultative reinsurance addresses individual risks or placements. Structured or finite-risk arrangements require particular attention to actual risk transfer, financial arrangements, and supervisory or accounting treatment.
These descriptions are contractual families rather than universal formulas. Quota-share commissions, profit commissions, sliding scales, loss corridors, portfolio transfers, indexation, exclusions, inuring order, and aggregate caps can change the net economics. An ORSA that represents every quota share as an unconditional constant percentage of every loss, or every excess-of-loss contract as a limitless annual protection, can materially misstate retention.
The program should be evaluated along at least four objectives: loss reduction in defined states; risk-capital effect under applicable measurement; counterparty and legal-credit exposure; and net value after premium, commissions, collateral expense, and financing. A low ceded-premium quote can be poor value if exclusions or reinsurer weakness make it ineffective under the scenarios for which it was purchased. Conversely, a treaty with a high expected price relative to expected recoveries may be rational when it protects a severe capital shortfall whose costs are nonlinear.
A transparent hypothetical event distribution
Consider a stylized one-year property insurer with four mutually exclusive gross event-loss states, each measured in USD millions. These states are constructed for illustration and are not calibrated from industry statistics. They describe a maximum relevant catastrophe event in the year and ignore all other claim components and expenses for this calculation.
| Gross event loss | Assumed probability | Occurrence recovery: $50m attachment, $200m limit | Contractual retained loss |
|---|---|---|---|
| $0m | 0.800 | $0m | $0m |
| $25m | 0.150 | $0m | $25m |
| $150m | 0.045 | $100m | $50m |
| $500m | 0.005 | $200m | $300m |
The gross expected loss is 0.150 × 25 + 0.045 × 150 + 0.005 × 500 = $13.0 million. Contractual expected recovery is 0.045 × 100 + 0.005 × 200 = $5.5 million. Contractual expected retained loss is therefore $7.5 million. The probabilities total exactly one; the retained and recovered amounts reconcile to gross loss state by state. For a purely illustrative ceded premium of $7.0 million paid before losses, a simplified expected retained loss plus premium is $14.5 million, compared with $13.0 million gross expected loss. That difference is a cost of protection in this narrow expected-cost comparison, not evidence that the treaty is economically undesirable. The expected cost of potential distress, capital scarcity, earnings volatility, taxes, and other objectives has intentionally been omitted.
The $500 million state yields a $300 million retained loss, despite the purchase of a $200 million layer. If the board's event-retention appetite is $250 million inclusive of treaty limit exhaustion, this program breaches appetite in that state. A different program with the same $50 million attachment and $300 million limit would produce $200 million retained loss in that state, but the additional protection has an unknown price, availability, and counterparty effect. The decision requires an actual quotation and a complete scenario comparison.
A 40% quota share, again ignoring exclusions, commissions, and any quota-share limits, would give expected ceded loss $5.2 million and expected retained loss $7.8 million in the four-state illustration. For the $500 million event its retained loss would also be $300 million; its treatment of the $25 million and $150 million states differs substantially from that of the excess-of-loss layer. Two programs with the same net extreme event in one state can thus generate very different earnings, expected recovery, credit exposure, and prospective risk profiles.
Counterparty realization, collateral, and concentration
Now suppose the extreme event occurs while a reinsurer representing the entire $200 million treaty recovery becomes unable to pay 50% of its otherwise valid amount. On this hypothetical stress assumption, ultimate recovery falls to $100 million and ultimate retained loss rises from $300 million to $400 million, before legal costs or other offsets. If legally effective, accessible collateral covers $60 million of the otherwise lost $100 million, ultimate retained loss instead becomes $340 million. That example does not imply collateral automatically converts into immediate cash: valuation, control, access, currencies, legal proceedings, and settlement terms must be examined.
A counterparty rating is an indicator rather than a substitute for analysis. The OSFI B-3 reinsurance guideline (effective January 1, 2025) emphasizes that although cessions reduce underwriting volatility, they generate counterparty, operational, legal, and liquidity risks. Its expectations for federally regulated cedents support a holistic evaluation of security and recoverability. The NAIC model-law inventory separately identifies the Credit for Reinsurance Model Law (#785) and Model Regulation (#786), whose actual domestic legal effect depends on the adopting jurisdiction and conditions. Financial protection and statutory recognition must be checked independently.
The EU risk-mitigation recognition conditions (Delegated Regulation (EU) 2015/35, Article 212) link recognition of specified techniques to qualitative requirements, policy consistency, reliable valuation, and relevant counterparty quality criteria. The technical rules involve other articles and the type of mitigation used; Article 212 is not a universal stand-alone assurance that all reinsurance is creditable. Governance must identify the particular provision and eligible transaction rather than transferring accounting treatment mechanically from another regime.
Exposure concentration also changes under protection. A cedent can diversify natural-hazard exposures geographically while concentrating recoverable balances in a handful of reinsurers whose financial health is exposed to the same catastrophe, capital-market, or interest-rate shock. The ORSA should examine each large group of reinsurers and common ultimate parent, collateral arrangements, and aggregate exposures after multiple events. Net modeled loss and gross treaty receivable are jointly relevant variables.
Market-cycle and renewal risk
A treaty purchased today may become unaffordable, narrower, or unavailable at renewal. The catastrophe-reinsurance market evidence of Froot (2001) links historically high pricing and limited high-layer purchase to risk-bearing supply conditions. The cross-country study of Altuntas, Garven, and Rauch (2018) indicates that firm characteristics alone do not explain all observed demand. Together, these findings support modeling the option set available at renewal, rather than treating the current contract and premium as a perpetual right.
A forward-looking policy can specify a fallback strategy for reduced market capacity: increased retention within limits, temporary reduction in exposed underwriting, additional capital, alternative risk transfer, changed deductibles, or geographically rebalanced growth. Every fallback changes the balance sheet and business plan. If the board's proposed response is simply to retain more risk, the ORSA must demonstrate how the higher retention interacts with appetite and solvency, including the possibility that the plan cannot be executed without cutting new business.
ORSA and Scenario Design
ORSA as prospective assessment
ORSA evaluates the insurer's own current and prospective risk management and solvency position. In the United States, the NAIC ORSA overview (NAIC) explains that Model #505 became effective in 2015 and that covered insurers or groups use regular confidential ORSA assessments, including stress scenarios and capital adequacy. The NAIC describes premium thresholds of more than $500 million for an individual insurer and more than $1 billion for a group, while applicable state law and exceptions govern a particular entity's legal obligation. ORSA is an ongoing ERM process rather than an annual standalone reporting exercise.
The NAIC enterprise risk management overview explains how integrated risk identification, assessment, and controls contribute to insurer governance. The NAIC ORSA guidance priorities describe 2026 clarification of current and prospective capital needs and the contributions of material risk categories. The NAIC states that a December 2026 manual update is expected; its completion should not be assumed as of November 15, 2026. State legislation and the operative ORSA manual govern specific reporting duties. Prospective capital analysis should explicitly test treaty renewal, reserve development, counterparty deterioration, and capital support against the insurer's actual portfolio.
The EU Solvency II ORSA requirement (Directive 2009/138/EC, Article 45) requires evaluation of overall solvency needs relative to specific risk profile, approved tolerance limits, and business strategy, continued capital and technical-provision compliance, and material deviations from assumptions underpinning the Solvency Capital Requirement. ORSA is documented and integrated into strategy; it is distinct from mechanically recalculating a regulatory capital formula.
The EIOPA ORSA guidelines (EIOPA, issued 2015; documentation subsequently made available in updated files) emphasize the governing body's active role in directing and challenging the assessment. A credible reinsurance component consequently tests both official capital treatment and the insurer's own view of risks that capital formulas may imperfectly capture, including nonmodeled legal exclusions, concentration, and severe cash timing.
In Canada, OSFI Guideline E-19 (effective January 1, 2018) describes ORSA as a tool linking risk profile to capital needs, solvency, and the setting of internal capital targets. It complements the reinsurer-risk expectations under B-3. The Canadian example demonstrates how a specific reinsurance policy must be assessed within prospective capital targets and the insurer's own risk methods.
Australian CPS 220 stress requirements require forward-looking scenario analysis and stress testing commensurate with a regulated entity's size, business mix, and complexity. The linked GPS 230 reinsurance requirements connect ReMS to business plans and ICAAP. ORSA is not the exclusive label for every country's forward-looking capital process; the functional comparison should recognize Australia's prudential use of ICAAP and risk-management terminology.
Scenario construction from gross risk to realization
A coherent reinsurance ORSA scenario begins with the same event and population of insured exposures through the full calculation. The sequence is: define an underwriting portfolio and exposure date; estimate gross claims by event, line, and legal entity; apply primary policy conditions; apply each treaty in its proper inuring order; enforce occurrence and aggregate limits; recognize reinstatements only if available under the wording and paid for when required; apply counterparty impairment, collateral, and basis risk; project settlement timing; and translate the resulting obligations into capital, liquidity, earnings, and prospective management actions.
The governing principle is traceability. A reinsurance recovery cannot be added to capital in a model if the scenario does not show the contract provision establishing that recovery. A counterparty is not diversified merely because several treaty panels list different legal names; an ultimate group or common collateral provider can create correlated exposure. An annual aggregate limit cannot be used independently for each catastrophe. A cash-flow plan cannot accelerate recovery dates solely because the ultimate treaty receivable is sound.
Scenario design should distinguish three logically different uncertainties. Aleatory uncertainty concerns the loss-producing event distribution conditional on selected assumptions. Epistemic uncertainty concerns catastrophe data, vulnerability estimates, liability development, contractual interpretations, and financial parameters. Decision uncertainty concerns future underwriting, purchase terms, availability of protection, and management response. These distinctions are established analytical categories, used here to organize governance judgment rather than to institute a new theory.
Capital stress and the failure of single-metric comfort
For a separate simplified balance-sheet illustration, assume eligible available financial resources of $450 million immediately before the $500 million gross event, with all other assets and liabilities held fixed in order to isolate reinsurance mechanics. Under the valid $200 million collection and $300 million retention, the resources remaining after ultimate economic recognition are $150 million. A predefined minimum internal headroom of $125 million is met by $25 million. Under the 50% counterparty payment failure described above, ultimate retention becomes $400 million and resources fall to $50 million, short of the internal headroom by $75 million. This illustration is not a regulatory SCR, MCR, RBC, or LICAT calculation and does not specify admissible capital components or taxes.
A single expected-loss comparison would miss this fragility. Gross expected loss in the first illustration was $13.0 million; expected contractual recovery $5.5 million. Yet the severe joint state is a capital shortfall relative to the assumed board target if the reinsurer cannot perform. The board should know both the probability assumptions and the potential financial consequences of counterparty stress. If reliable probabilities for joint catastrophe and reinsurer failure are unavailable, the scenario remains a disciplined deterministic stress rather than a justified probabilistic capital estimate.
Cash and collateral timing
Suppose the $500 million catastrophe requires cash settlement promptly, while reinsurers are expected to pay the contractually due $200 million after 90 days. The cedent starts with $220 million in unencumbered liquid assets specifically available to meet these claims and has an additional committed facility that can supply $180 million subject to its contractual conditions. Its immediate funding gap is $500 million − $220 million − $180 million = $100 million before other payments and realizable asset sales. The ultimate valid recovery does not close the immediate gap unless an available advance, bridging facility, or other source supplies funds in time.
If a portion of the delayed recovery amount, say $200 million, must be bridged for 90 days at a purely illustrative simple annual financing rate of 6%, the hypothetical carrying cost is $200 million × 0.06 × 90/365, approximately $2.96 million. This is an alternative cash-funding calculation, not an assertion that the stated $180 million facility can cover all $200 million. Fees, compound interest, margins, collateral terms, and rate changes are omitted. The funding gap and the carrying cost measure different quantities.
Liquidity risk depends on the gross claims-payment path and the timing of actual collections, not merely on the retained ultimate claims measure. An insurer that reports only a net annual claims figure can understate the cash needed to protect policyholders before reinsurance is settled. Senior management should therefore synchronize ORSA with treasury forecasts and counterparty collections.
Multiple events, aggregation, and reverse stress
The four-state calculation deliberately assumes one relevant maximum event. To test treaty exhaustion, construct a second independent scenario with three covered catastrophe occurrences of $150 million each within one contract year. Assume the program provides one $200 million total annual recovery capacity, a $50 million occurrence attachment, no reinstatement, and valid coverage under each event definition. Without the annual cap, the contractual recovery would be $100 million per event or $300 million in total. Because aggregate capacity is only $200 million, actual total recovery is $200 million and cumulative retained loss is $450 million − $200 million = $250 million. A model that gives $300 million of recovery violates its own annual-cap assumption.
The scenario can be extended by testing different event timings. If the first two events exhaust the treaty, a third may be entirely net. If the first event occurs before the next renewal, underwritten exposure may change. If the treaty is reinstatable upon additional premium, availability, number of reinstatements, and cost must be specified. A clustering scenario is particularly important where the statistical dependence of extreme events is poorly resolved and a portfolio has seasonally concentrated exposure.
Reverse stress testing begins with the event that would violate a defined objective and then explores the paths that could produce it. For example, the cedent's $125 million internal minimum resources might fail through a $500 million gross event combined with a $100 million recovery shortfall, but also through two moderate events and aggregate treaty exhaustion or a severe renewal capacity contraction. The reverse exercise should identify the first breached constraints, possible preventive management responses, and their executable time frames.
A prospective multi-year ORSA would also model premium growth, rates, inflation, reserve development, investment returns, new reinsurance prices, counterparty changes, and profit retention. Scenario actions should be constrained by actual contractual notice periods, capital-market access, regulator requirements, and operational implementation capacity. The use of a management action as an automatic capital restoration is justified only when credible evidence supports its feasibility and timing.
Model and parameter governance
A catastrophe model can inform gross loss distributions, but the insurer is responsible for understanding exposure coding, hazard assumptions, vulnerability functions, secondary uncertainty, geographic coverage, and model change. A reserve-development model may capture different loss drivers and time scales. Reinsurance aggregation typically requires both. The board should receive an explanation of why a model's output is appropriate for treaty placement, ORSA, or both.
Data reconciliation is a core control. Written premium and insured values must match the underwriting portfolio being modeled; attachment and limit information must match signed treaties; reinsurer participations must sum to the placed line; aggregate exhaustion must reconcile across claims and treaty years; and recoverable balances must reconcile with counterparty and collateral records. Differences should be measured and escalated according to materiality.
The most important scenario limitations are often structural: implicit independence of hazard and counterparty default; fixed treaty coverage under growth; static reinsurance cost; unchanged reinsurer rating after a catastrophe; immediate collection of future receivables; fixed reserve adequacy; and unlimited access to parent resources. ORSA integration improves when those assumptions become explicit alternative stress narratives rather than hidden default settings.
Monitoring, Audit, and Supervisory Reporting
Operational controls between renewal dates
Reinsurance governance requires controls throughout the treaty life cycle. Before placement, the cedent assesses exposures, options, pricing, counterparties, security, and legal terms. At binding, it confirms authority, placement percentages, effective dates, scope, and evidence of commitment. During the coverage period, it tracks exposure drift, claims notifications, recoveries, collateral, aggregate usage, treaty amendments, and counterparty condition. At renewal or termination, it reassesses structure, claims experience, alternative terms, and residual obligations.
APRA GPS 230 specifies an inception-date rule requiring written evidence of binding by inception and a two-month rule for possession of full legally binding treaty documentation in the applicable arrangements. It requires a Reinsurance Arrangements Statement, and an annual reinsurance declaration for insurers within the detailed conditions of the standard. These are material documentary controls, not merely administrative conveniences: a model assumption of full protection should be checked against the actual timing and completeness of legal binding evidence.
The same standard's reporting content identifies concrete information that a governance dashboard may use, including program schematics, occurrence and aggregate deductibles, reinstatements, reinsurer participation by layer, gross exposures, net retentions, catastrophe limits, and limited-risk-transfer arrangements. An insurer in another jurisdiction may not have identical reporting duties, but the operational need to reconstruct the actual financial program is broadly relevant.
A practical control and evidence matrix
The following matrix is an analytical synthesis of cited supervisory expectations. Its rows describe functions rather than a uniform legal mandate across the five jurisdictions.
| Control domain | Required management evidence | ORSA linkage | Primary review question |
|---|---|---|---|
| Strategy and authority | Board-approved risk appetite, program objectives, delegated approvals | Material risk limits and solvency needs | Does the purchased program implement the approved purpose? |
| Exposure and modeling | Portfolio reconciliations, model assumptions, independent challenge | Gross scenarios and uncertainty | Do the model and treaty cover the same risks and dates? |
| Binding and wording | Signed treaties, slips, schedules, amendments, legal analysis | Contractual loss transformation | Is the modeled recovery enforceable under each stress? |
| Counterparty and collateral | Reinsurer group exposure, financial condition, collateral control | Credit and concentration risk | Can collections survive a correlated extreme event? |
| Claims and recoveries | Notices, balances, cash receipts, disputes, aging | Liquidity path and capital recognition | Are ultimate and timed recoveries kept separate? |
| Program exhaustion | Aggregate usage, reinstatement status and costs | Multiple-event stresses | Does remaining cover match the model assumption? |
| Renewal and market access | Quotes, alternative structures, capacity and price sensitivity | Multi-year prospective solvency | Can the insurer execute its fallback plan? |
| Assurance and oversight | Independent review results, exceptions, board minutes | ORSA challenge and remediation | Who owns each finding, deadline, and escalation? |
The matrix is useful only if populated with actual entity-level records. A generic statement that the insurer has adequate reinsurance cannot establish whether an occurrence definition was applied correctly or whether the counterparty responsible for a large receivable has sufficient security. Supervisory expectations are strongest when translated into records that allow independent reconstruction.
Recovery monitoring and early warnings
Recoverable balances need aging by counterparty and treaty, currencies, collateral, dispute status, and expected collection dates. The risk function should compare those reports with ORSA assumptions. Early-warning indicators may include a large movement in gross exposure after acquisitions, increasing net catastrophe probable maximum loss, weakening reinsurer credit, repeated late recoveries, unexpected claims dispute frequency, approaching aggregate exhaustion, concentrated renewal dates, and planned underwriting growth beyond treaty coverage.
Escalation policy should identify which indicators require management attention, committee review, or immediate board notification. A breach is a governance event because it changes the institution's relation to its approved risk appetite; the operational task is to change exposure, risk transfer, capital resources, or limits through an authorized decision. Recording an exception without a credible response leaves the risk decision incomplete.
Internal audit and independent review
Internal audit assesses whether controls were designed appropriately and operated, using records rather than trusting dashboard summaries. It can test selected loss events end to end: underwriting policy to claims reserve, treaty section, reinsurance claim, counterparty debit, collateral, cash receipt, and ultimate accounting outcome. For scenario controls, audit can inspect whether material changes to treaty wording or exposure were transferred into the ORSA data pipeline and whether management-action assumptions were approved.
Independent review should respect responsibilities. The program owner and risk function can validate calculations and management assumptions; internal audit should retain organizational independence in evaluating those controls. Formal actuarial opinions, legal opinions, and regulatory submissions depend on applicable national rules and the specific work undertaken. Neither an external catastrophe model nor a broker-supplied program analysis can replace the insurer's internal control obligations.
International reporting comparison
The NAIC's U.S. ORSA reporting description specifies an at-least-annual assessment by entities within the applicable threshold, documented processes, and a confidential high-level ORSA Summary Report. It describes submission arrangements involving the lead state commissioner and domiciliary regulator, subject to the governing state framework. Confidentiality is an important research constraint: the existence of a summary-report requirement cannot establish what any particular insurer has disclosed privately.
The EIOPA Article 45 rule connects ORSA to an insurer's solvency needs and the supervisory information architecture of Solvency II. It operates alongside Articles 44 and 260 and applicable European supervisory guidance. The financial transformation produced by reinsurance must be relevant to both the risk system and the assessment of capital and own funds, with recognition governed by the applicable detailed rules.
The Canadian OSFI E-19 guidance emphasizes enterprise-level understanding of risk and capital targets. The OSFI B-3 expectations address sound ceded reinsurance practices. The Australian GPS 230 standard requires the relationship between reinsurance management, business planning, ICAAP, and defined supervisory submissions. Terminology and reporting formats differ, but in each system the supervisor needs evidence that risk transfer is a governed and financially intelligible component of risk management.
The IAIS ICP 13 peer-review results (2026) provide an international supervisory implementation benchmark, not a treaty-level validation dataset. Researchers should resist converting the aggregate rating distribution into firm-level outcomes. The evidence needed for firm-level effectiveness includes actual cessions, contract claims, payment timing, governance records, and outcomes, subject to confidentiality.
Audit trails and analytical provenance
A reinsurance ORSA audit trail should record the exposure dataset date, model version, event catalog or statistical assumptions, policy and treaty terms, counterparty participations, collateral treatment, scenario parameters, control approvals, and final report version. It should allow an independent reviewer to reproduce both the calculation and the reasoning behind the management decision. A model output with no treaty-year provenance cannot reliably explain capital changes after a program renewal.
The strongest evidence architecture is bidirectional. A board risk limit points to the scenario, scenario to gross exposure and model, model result to contract wording and counterparty allocation, recoverable to actual collection controls, and revised projections back to the board decision. Material exceptions should be documented as changes in this chain. This is a synthesis of practical control relationships, not a proposed proprietary standard.
Cross-Framework Synthesis, Research Gaps, and Conclusions
Shared requirements and substantive differences
The international comparison reveals convergence on the need for organizational accountability, written strategy, assessment of actual risk transfer, and a relationship between risk mitigation and solvency. Convergence does not erase differences of legal force, supervisory process, and reporting convention. IAIS ICPs articulate internationally accepted supervisory expectations. The EU specifies an ORSA obligation in a directive and related risk-management and risk-mitigation rules. U.S. requirements depend on state adoption and the NAIC model framework, including its premium thresholds and confidential summaries. APRA expressly links reinsurance management to a board-approved strategy, ICAAP, and detailed contract-documentation and reporting expectations. OSFI coordinates forward-looking insurer capital assessment with sound reinsurance practice through guidelines.
For the research question at hand, this yields a precise institutional synthesis. A decision to buy reinsurance has three representations: the authorized business and risk decision, the legally operative financial transfer, and the prospective condition of the cedent after the transfer. Defects arise when one representation is substituted for another. Board approval does not make a disputed treaty collectible; an enforceable receivable does not immediately produce liquidity; a reduction in measured capital does not ensure protection against a newly concentrated counterparty failure.
A comparative supervisory matrix captures the main evidence:
| Framework | Supervisory emphasis | Principal reinsurance–solvency integration point | Interpretive limit |
|---|---|---|---|
| IAIS ICP 13 and ICP 16 | Program fit, board oversight, counterparty exposures, all-material-risk ORSA | Risk-transfer design reconciled with overall ERM and prospective financial resources | Standards depend on jurisdictional implementation |
| EU Solvency II | Risk-management system, ORSA, qualitative recognition of mitigation | Written policy, own solvency needs, capital and technical provisions, risk mitigation eligibility | Detailed rules and supervisory guidance determine individual treatment |
| United States NAIC model framework | Ongoing group and entity risk assessment, confidential ORSA summary, credit for reinsurance | Treaty and counterparty exposures reflected in future capital and risk assessment | State law and covered-entity thresholds control obligations |
| Australia APRA | ReMS, board accountability, program documentation, ICAAP, supervisory reinsurance submissions | Binding contracts and program operation reconciled with risk appetite and capital planning | Applies to institutions and arrangements within the prudential standards' scope |
| Canada OSFI | Own assessment, internal capital targets, sound reinsurance practices | Counterparty, legal, and liquidity risks included alongside reduced insurance exposure | Guidelines state OSFI expectations for federally regulated entities |
Economic interpretation: pricing, security, and institutional value
The insurer's choice can be expressed as a constrained evaluation of a feasible set of reinsurance programs. Let P denote a particular program, including contractual terms and counterparty panel, and let K denote available financial resources. Each option induces distributions for retained losses, paid premiums, ultimate collections, and short-term liquidity requirements. An analytical decision can compare expected cost and risk measures while imposing risk-appetite, legal, market-capacity, and capital constraints. This formulation organizes established financial reasoning; it is not a newly claimed optimization theory.
Crucially, the cost of reinsurance is not only its quoted premium. A sound comparison includes commissions, collateral costs, tax or accounting effects where relevant, renewal optionality, claims-collection financing, operational complexity, basis risk, and the cost of holding net capital against residual risk. A cheaper nominal treaty may lose value when modeled collections are delayed or highly uncertain. A higher-priced layer may be justified if it protects binding capital constraints and supports a viable underwriting portfolio.
Mayers and Smith (1990) and Altuntas, Garven, and Rauch (2018) show that firm structure and country setting help explain observed cession decisions. Froot (2001) shows that catastrophe capacity and pricing have historically limited the transfer purchased. Cole and Eastman (2026) associate reinsurance use with firm life-cycle characteristics in their financial-firm sample. This literature supports heterogeneity in governance objectives and feasible market transactions, while its observational designs cannot establish the causal benefit of every individual cedent's chosen program.
Material research gaps
The literature and supervisory record leave several empirical gaps directly relevant to this object. Confidential ORSA submissions restrict the ability of outside researchers to connect board judgment and scenario design to subsequent performance. Published reinsurance disclosures often lack the contract wording, aggregate limits, collateral terms, and payment timelines necessary to reconstruct net risk precisely. Reinsurer failure and catastrophe occurrence are rare, potentially dependent tail events, making joint probabilities difficult to estimate. Group reinsurance arrangements complicate entity-level inference. Model validation can be limited by proprietary exposure datasets and catastrophe-engine specifications.
Research on program effectiveness would benefit from securely accessible, anonymized treaty-year panels linking cedent exposure, program terms, realized recoveries, payment lags, collateral access, and supervisory risk measures. Comparisons should control for underwriting selection and changing risk appetite: an insurer may purchase more reinsurance because its underlying risk has increased. Without that distinction, a correlation between heavy cession and subsequent adverse outcomes may be misinterpreted as an effect of reinsurance.
Prospective multi-year governance also raises questions about endogenous policy and market response. An insurer facing severe losses may seek more reinsurance precisely when market capacity and prices deteriorate. Capital may be raised, underwriting reduced, or treaties restructured, but those responses depend on real execution constraints. Models that take management action as freely available under every state of the world can materially overstate solvency. Evaluating these assumptions against actual historical execution would strengthen ORSA research.
Decision consequences
The practical consequence of the comparison is an obligation to keep the decision chain internally consistent. First, identify the risk to be transferred and the board's acceptable residual exposure. Second, demonstrate contractually what the program transfers, including limits, dates, exclusions, and counterparty participations. Third, assess realistic ultimate collection and cash timing, under ordinary and severe conditions. Fourth, measure current and prospective capital and liquidity using the same exposure and treaty assumptions. Fifth, monitor differences as portfolios, financial conditions, claims, and market prices change. Sixth, preserve evidence of who authorized decisions, challenged assumptions, and acted on exceptions.
These steps do not prescribe an identical reinsurance portfolio to all insurers. Their value is traceability of the institution's own choices, allowing a sophisticated insurer to purchase complex programs and a smaller insurer to implement proportionate controls. Decision quality becomes measurable through the ability to reconstruct why a treaty was bought, what outcomes it protects, how it might fail, and what the institution would do when it fails.
A limiting principle follows. Reinsurance program governance is effective only to the extent that its representations correspond to enforceable rights and feasible institutional action. ORSA integration is effective only to the extent that those rights and actions appear in prospective financial assessment with their costs, dependencies, and limitations. A program that transfers a loss in a model but cannot generate timely collectible resources under its intended stress has not achieved the whole risk-management objective.
Conclusion
Reinsurance governance and ORSA integration belong to a continuous insurer decision process. A reinsurance purchase transforms the distribution of legally transferable loss; it also creates receivables, dependence on counterparties, settlement lags, operational obligations, and potential gaps between modeled and realized financial protection. Risk appetite defines why the transfer is purchased. Board oversight defines who authorizes and challenges that decision. Treaty documentation defines what can be collected. ORSA tests how the resulting institution meets obligations through adverse and changing future states.
International supervisory sources converge on accountability, coherent risk strategy, actual transfer effectiveness, and prospective solvency, while remaining jurisdiction-specific in their normative force and operational requirements. The examined scholarly literature establishes that insurer structure, country context, financial constraints, market supply, and corporate life cycle affect reinsurance demand. These findings justify insurer-specific evaluation rather than a single ideal cession ratio.
The hypothetical calculations show that $13.0 million of gross expected event loss can coexist with $5.5 million of expected treaty recovery and a severe $300 million retained event loss; that counterparty nonperformance can increase this ultimate retained event loss to $400 million; and that an ultimate $200 million recovery may still leave a $100 million immediate cash funding gap under the stated liquidity assumptions. These are transparent examples, not empirical parameter estimates. They establish why expected cost, retained tail loss, recoverability, available capital, and timed liquidity must remain separate but connected decision measures.
The resulting scientific conclusion is that credible integration has three verifiable properties: every material recovery has a documented contractual basis; every material stress treats gross claims, net retention, counterparty performance, and cash timing consistently; and every resulting variance can be traced to an accountable governance response. This is an original analytical synthesis of established regulatory and academic findings. It creates no named new theory or doctrine and makes no unsupported claim to external peer review or firm-level empirical validation.
References
Altuntas, M., Garven, J. R., & Rauch, J. (2018). On the corporate demand for insurance: Evidence from the global reinsurance market. Risk Management and Insurance Review, 21(2), 211–242. https://doi.org/10.1111/rmir.12107 ; verified publisher record: https://onlinelibrary.wiley.com/doi/10.1111/rmir.12107
Australian Prudential Regulation Authority (APRA). (2019). Prudential Standard CPS 220: Risk Management (in force July 1, 2019). https://www.apra.gov.au/standards/cps-220
Australian Prudential Regulation Authority (APRA). (2023). Prudential Standard GPS 230: Reinsurance Management (effective July 1, 2023). https://www.apra.gov.au/standards/gps-230
Cole, C. R., & Eastman, E. M. (2026). Risk management and corporate lifecycles: Evidence from reinsurance purchases. Journal of Corporate Finance, Article 102961. https://doi.org/10.1016/j.jcorpfin.2026.102961 ; verified publisher record: https://www.sciencedirect.com/science/article/pii/S0929119926000192
European Insurance and Occupational Pensions Authority (EIOPA). (2015). Guidelines on Own Risk and Solvency Assessment (ORSA). https://www.eiopa.europa.eu/publications/guidelines-own-risk-solvency-assessment-orsa_en
European Insurance and Occupational Pensions Authority (EIOPA). (2024). Solvency II Single Rulebook: Article 259, Risk Management System (Delegated Regulation (EU) 2015/35). https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-5920_en
European Insurance and Occupational Pensions Authority (EIOPA). (2024). Solvency II Single Rulebook: Article 260, Risk Management Areas (Delegated Regulation (EU) 2015/35). https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-5922_en
European Insurance and Occupational Pensions Authority (EIOPA). (2024). Solvency II Single Rulebook: Article 212, Financial Risk-Mitigation Techniques (Delegated Regulation (EU) 2015/35). https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-5866_en
European Insurance and Occupational Pensions Authority (EIOPA). (n.d.; accessed November 15, 2026). Solvency II Single Rulebook: Article 44, Risk Management (Directive 2009/138/EC; online consolidated text). https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-2127_en
European Insurance and Occupational Pensions Authority (EIOPA). (n.d.; accessed November 15, 2026). Solvency II Single Rulebook: Article 45, Own Risk and Solvency Assessment (Directive 2009/138/EC; online consolidated text). https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-2128_en
Froot, K. A. (2001). The market for catastrophe risk: A clinical examination. Journal of Financial Economics, 60(2–3), 529–571. https://doi.org/10.1016/S0304-405X(01)00052-6 ; verified publisher record: https://www.sciencedirect.com/science/article/pii/S0304405X01000526
International Association of Insurance Supervisors (IAIS). (2024). Insurance Core Principles and ComFrame: ICP 13, Reinsurance and Other Forms of Risk Transfer (revisions adopted December 5, 2024). https://www.iais.org/icp-online-tool/13524-icp-13reinsurance-and-other-forms-of-risk-transfer/
International Association of Insurance Supervisors (IAIS). (2024). Insurance Core Principles and ComFrame: ICP 16, Enterprise Risk Management for Solvency Purposes (revisions adopted December 5, 2024; online tool). https://www.iais.org/icp-online-tool/
International Association of Insurance Supervisors (IAIS). (2026, April 21). IAIS publishes aggregate report on the peer review process on ICP 13 (Reinsurance and Other Forms of Risk Transfer). https://www.iais.org/2026/04/iais-publishes-aggregate-report-on-the-peer-review-process-on-icp-13-reinsurance-and-other-forms-of-risk-transfer/
Mayers, D., & Smith, C. W., Jr. (1990). On the corporate demand for insurance: Evidence from the reinsurance market. The Journal of Business, 63(1), 19–40. https://doi.org/10.1086/296481 ; checked bibliographic record: https://ideas.repec.org/a/ucp/jnlbus/v63y1990i1p19-40.html
National Association of Insurance Commissioners (NAIC). (2025). Reinsurance (Insurance Topics; updated October 24, 2025). https://content.naic.org/insurance-topics/reinsurance
National Association of Insurance Commissioners (NAIC). (n.d.; accessed November 15, 2026). Own Risk and Solvency Assessment (Insurance Topics; including Model #505 and ORSA Guidance Manual background). https://content.naic.org/insurance-topics/own-risk-and-solvency-assessment
National Association of Insurance Commissioners (NAIC). (n.d.; accessed November 15, 2026). Enterprise Risk Management (Insurance Topics; background page last updated May 9, 2024). https://content.naic.org/insurance-topics/enterprise-risk-management
National Association of Insurance Commissioners (NAIC). (n.d.; accessed November 15, 2026). Model Laws (catalog of Model #505 and Credit for Reinsurance Model Law #785 and Model Regulation #786). https://content.naic.org/model-laws
Office of the Superintendent of Financial Institutions Canada (OSFI). (2018). Guideline E-19: Own Risk and Solvency Assessment (effective January 1, 2018). https://www.osfi-bsif.gc.ca/en/guidance/guidance-library/own-risk-solvency-assessment
Office of the Superintendent of Financial Institutions Canada (OSFI). (2025). Guideline B-3: Sound Reinsurance Practices and Procedures (effective January 1, 2025). https://www.osfi-bsif.gc.ca/en/guidance/guidance-library/sound-reinsurance-practices-procedures-guideline-2025